Trial Profile
Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Diquafosol (Primary) ; Hyaluronic acid
- Indications Dry eyes
- Focus Therapeutic Use
- 20 Nov 2015 New trial record